HER2-low mBC patients report preserved QOL with trastuzumab deruxtecan
HER2-low mBC patients report preserved QOL with trastuzumab deruxtecan
Extended adjuvant AI not advised for HPBC after 5+ yrs of sequential endocrine therapy
Prognostic model of all-cause mortality at 30 days in patients with cancer and COVID-19
New data presented at ESMO for multi-cancer early detection
Olaparib continues to show positive results in advanced ovarian cancer - 7 year data
How air pollution may trigger lung cancer in never-smokers
Tumour-infiltrating lymphocyte treatment for advanced melanoma
Nirogacestat success for desmoid tumours
OncoAlert and ecancer weekly round up for August 15th - 21st, 2022
An overview of treatment advances in gastric cancer
Optimum treatment strategy algorithm for mCRC
OncoAlert and ecancer weekly round up for August 8th - 14th, 2022